Join us at EFMC Medicinal Chemistry 2026
Dates:
September 6–10, 2026
Location:
Congress Center Basel | Basel, Switzerland
Booth #6
Don’t miss our poster:
📌 Antibody-Oligonucleotide Conjugates: From Stochastic Purification to Site-Specific Conjugation
ChemPartner Attendees: Phil Clarke, Ian Willox
Join the global medicinal chemistry community at EFMC Medicinal Chemistry 2026 in Basel — one of Europe’s premier gatherings for scientists advancing drug discovery across small molecules, biologics, and emerging modalities.
While at the symposium, meet our experts, Phil Clarke and Ian Willox, at Booth #6 for a conversation on ChemPartner’s integrated chemistry capabilities — from medicinal and synthetic chemistry through bioconjugation, DMPK, and IND-enabling development.
Stop by our poster session to explore our latest work on antibody-oligonucleotide conjugates (AOCs), where we share how our teams are moving beyond stochastic conjugation and purification toward robust, site-specific conjugation strategies that improve homogeneity, yield, and developability for next-generation conjugate therapeutics.
Let’s Connect:
Whether you’re optimizing a lead series, designing a conjugate program, or planning your path to IND, our team would love to hear about your goals and discuss how ChemPartner can support your program.
Questions? Contact us
